Figure 5.
Immunostaining of DEFA4 in cystadenolymphoma. Primary magnification 5-fold (A), 10-fold (B), 20-fold (C) and 40-fold (D).
Winter et al. BMC Cancer 2012 12:465 doi:10.1186/1471-2407-12-465 |
Figure 5.
Immunostaining of DEFA4 in cystadenolymphoma. Primary magnification 5-fold (A), 10-fold (B), 20-fold (C) and 40-fold (D).
Winter et al. BMC Cancer 2012 12:465 doi:10.1186/1471-2407-12-465 |
